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Cross-sectional experimental study was conducted with the objective to estimate the seroprevalence 
on the basis of antibodies to VP7 protein of bluetongue virus by competitive enzyme linked 
immunosorbent assay (c-ELISA), to test the neutralizing ability of the antibody to reference strains of 4 
BTV serotypes (BTV-1, 2, 10 and 23) by micro serum neutralization assay (m-SNT), to check the 
presence of BTV dsRNA and to isolate and characterize bluetongue virus (BTV). A total of 91 serum and 
26 whole blood samples were obtained from sheep and goat. The study was conducted between 
September and November, 2012 when the culicoides midges’ activity is maximal. The animals were 
observed for clinical signs of BTV infection and serum samples were obtained from all animals for c-
ELISA and m-SNT. Further, blood samples were collected from the c-ELISA positive animals and 
subjected to virus isolation and nested RT-PCR. Out of 91 animals tested, 26 (28.6%) were found to be 
seropositive by c-ELISA and one sheep showed neutralizing antibody against BTV-1 serotype at a titer 
of 1.2 log10. Multivalent logistic regression analysis of risk factors like age, sex, body condition and 
species of animals were considered during the serological study and found that species of animal had 
significant influence (χ
2 
= 17.111, P<0.05) in seropositivity of BTV. Goats showed more seropositivity to 
bluetongue as compared to sheep (OR = 0.233). Other risk factors had no significant influence (P>0.05) 
on seropositivity. It was worth enough to conclude that higher seroprevalence among goats indicated 
that goats would be the most important animals in the epidemiology of BTV with less clinical 
manifestation due to development of acquired immunity as the result of continuous exposure. 
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Bluetongue (BT) is an arthropod-transmitted hemorrhagic 
disease of wild and domestic ruminants. It is enzootic in 
many tropical, subtropical and some temperate regions, 
including much of the Americas, Africa, southern Asia 
and northern Australia, coincident with the geographic 
distribution and seasonal activity of competent Culicoides 
vector insects (Purse et al., 2005, 2009). 
Bluetongue virus (BTV) is the prototype of the genus
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Orbivirus in the family Reoviridae (Van Regenmortel, 
2003; Mertens et al., 2004). Currently, there are 26 
recognized serotypes (BTV-1 to -26) with recent additions 
of the 25
th
 serotype (“Toggenburg orbivirus”) from 
Switzerland in goat and 26
th 
serotype from Kuwait in 
sheep and goat (Hofmann et al., 2008; Maan et al., 2011, 
2012; Batten et al., 2013). There is only low level of 
cross-protection among the BT virus serotypes and making 
vaccination strategies and control programmes a daunting 
task (Hofmann et al., 2008; Eschbaumer et al., 2009). 
BTV is almost exclusively spread by Culicoides spp. 
biting midges (Diptera) and occurs worldwide and its spread 
increased in association with the climate change (Purse 
et al., 2005). All 26 serotypes can cause BT, a non-conta-
gious hemorrhagic disease of domestic and wild rumi-
nants and camelids with no known zoonotic potential 
(Verwoerd and Erasmus, 2004; Batten et al., 2013). BT is 
a multiple species disease to the OIE, World 
Organisation for Animal Health (OIE, 2013) and notifiable 
to veterinary authorities in many countries (Eschbaumer 
et al., 2009). BT primarily affects sheep and deer, but 
clinical disease in cattle does occur. The worldwide eco-
nomic losses due to BT have not been expressed in exact 
numbers, but the estimate is 3 billion US$ a year 
(Tabachnick, 1996; Sperlovaand Zendulkova, 2011). It 
can have considerable economic impact, both directly by 
deaths and decreased productivity and indirectly by trade 
losses through animal movement restrictions (Verwoerd 
and Erasmus, 2004). 
The OIE recommended complement fixation test (CFT), 
Agar gel immunodiffusion (AGID) and competitive enzyme 
linked immunosorbent assay (c-ELISA) as tests for 
international trade for BT disease screening (OIE, 2008). 
Many research results has declared that the competitive 
ELISA technique that detect antibodies directed against 
the VP7 core protein can be applied to all 26 BTV sero-
types, and this technique is highly sensitive and specific 
(Khalid et al., 2012).The specificity is gained by the use 
of the monoclonal anti-VP7, which is the protein that 
distinguishes the BT serogroup from other Orbivirus 
serogroups, representing the preferred method to deter-
mine and monitor BTV circulation (Afshar et al., 1992; 
Afshar et al.,1993; De et al., 2009; Khalid et al., 2012). 
The diagnostic sensitivity and specificity of c-ELISA is 
87.8% (85.1 to 91.1) and 98.2% (96.3 to 99.6) respect-
tively, and it is considered as the first choice for the 
serological surveillance of BT in susceptible animals/herd 
(Vandenbussche et al., 2008). 
Based on virus isolation and serological studies, 21 
serotypes have been recorded in different parts of India 
to date (Ramakrishnan et al., 2005; Dahiya et al., 2004). 
Realizing the importance of BT in India, Indian Council of 
Agricultural Research (ICAR) has launched an All India 
Network Program on BT in an attempt to isolate the virus 
in embryonated chicken eggs and cell culture system, 
molecular characterization, maintenance of repository, 





besides epidemiology, prevention and control.  
This study was carried out with the objectives to deter-
mine the seroprevalence of BT by c-ELISA and the 
neutralizing ability of the antibody to 4 reference BTV 
serotypes (BTV-1, 2, 10, and 23) by micro serum neutrali-
zation assay (m-SNT), to check the presence of the virus 
by nested RT-PCR and finally to isolate and identify the 
virus from the blood samples. 
 
 
MATERIALS AND METHODS 
 
Study animals and experimental design  
 
Cross-sectional experimental study was conducted between Sep-
tember and November 2012 in sheep and goats in Uttar Pradesh, 
India. A total of 91 (58 sheep and 33 goats) were included in this 
study. Both males and females of different age groups were part of 
the study.  
 
 
Sample collection and testing 
 
10 ml of blood was collected aseptically from the jugular vein of 
each animal of which 5 ml was mixed with anticoagulant (EDTA1.5 
mg/ml) for antigen detection and 5 ml for serum separation for BTV 
antibody detection. Serum and whole blood were collected from 
animals and serum was stored at 4°C until analyzed by c-ELISA, m-
SNT and whereas blood samples were immediately sent for nested 
RT-PCR and virus isolation. 
 
 
Competitive enzyme linked immunosorbent assay (c-ELISA) 
 
The c-ELISA was carried out in this study because it is less subject-
tive than serum neutralization test (SNT) techniques and is able to 
discriminate BTV from another closely associated Orbivirus, Epi-
zootic Hemorrhagic Disease virus (EHDV). Serum samples were 
centrifuged at 3,000 x g for 5 min and serum was removed using a 
sterile transfer pipette. The detection of BTV specific antibodies in 
serum was carried out using competition ELISA assays (Pourquier 
c-ELISA kit (IDEXX, UK) according to the manufacturer’s instruct-
tions. Results were reported as positive or negative and percent 
competition based on optical density readings at 450 nm by ELISA 




Micro-serum neutralization test (m-SNT) 
 
The micro serum neutralization test (m-SNT) was used to further 
confirm the positive c-ELISA results. The m-SNT was performed 
according to the method of Haig et al. (1956), Oura et al. (2009) 
and Batten et al. (2013). The reference viruses (BTV 1, 2, 10 and 
23) maintained in the virus laboratory of CADRAD, IVRI, Izatnagar, 
Uttar Pradesh were used in the study. 50 μl of serial 2 fold sera 
dilutions starting from 1:2 to 1:256 were added to each well of flat-
bottomed microtitre plates and mixed with an equal volume of stan-
dard reference BTV serotypes 1, 2, 10, and 23 which are prevalent 
in India containing 100 TCID50 followed by incubation at 37°C in 




 concentration were added per well and incubated for 72 h.  The 
plates were examined under the inverted microscope for the pre-
sence of cytopathic effect (CPE). A sample was considered positive 
when it showed a CPE of more than 50% neutralization at the 
lowest dilution (1:2). The neutralization titer was determined as




Table 1. Nested PCR primers and cycling conditions. 
  
Genes and primer 
position  
Primer sequence (5’-3’) 
Length (bp) Annealing temperature 
(°C) 
Nucleotide 




















the dilution of serum giving a 50% neutralization end point. m-SNT 
antibody titers were expressed as log10 reciprocal of the highest 
positive serum dilution. 
 
 
Viral dsRNA extraction 
 
Blood samples were subjected to the following pre-treatment before 
RNA extraction: 250 µl of red blood cells were washed with PBS 
and lysed with 1 ml distilled water. It was centrifuged at 10,000 × g 
for 10 min, the supernatant was discarded and the pellet was resus-
pended in 250 µl DEPC water. Total RNA was extracted either from 
250 µl lysed red blood cells or 250 µl supernatant from infected 
BHK-21 cells with 750 µl Trizol-LS reagent (Life Technology, USA), 
according to the method recommended by the manufacturer. The 
precipitated RNA was suspended in 30 µl DEPC water.  
 
 
Nested reverse transcription polymerase chain reaction (RT-
PCR) 
 
RT-PCR was done with two steps as described by Wade Evans et 
al. (1990). Reverse transcription was done in a final volume of 20 µl 
from BTV dsRNA using segment 5 (NS1) gene specific primers 
(OIE, 2008) and MMLV-RT (Promega, USA) according to manufac-
turer’s protocols. The primers were custom synthesized by M/s 
Eurofins, Bangalore. The details of the primer set are given in Table 
1. 
The cDNA mix containing 4 ul of BTV ds RNA (500 ng), 1 ul of 
forward primer (20 pmol), 1 ul of reverse primer (20 pmol) and 3 ul 
of DPEC treated water was prepared in 0.5 ml centrifuge tube. This 
reaction mixture was incubated at 94°C for 4 min for denaturation of 
dsRNA and to remove secondary structure and then chilled on ice 
for annealing of primer. 10 µl of the master mix contains  4 µl of 
5×Reaction buffer (50 mM Tris/HCl, pH 7.5, 3mM MgCl2 and 75 mM 
KCl) (Thermoscientific, USA), 1 µl of  dNTP mix (10 mM each 
dATP, dCTP, dGTP, dTTP), 2 µl  DTT (0.1 M), 1.5 μl of  DEPC 
water, 0.5 µl of Ribolock
TM
 (Ribonuclease-inhibitor) (Fermentas, 
USA) (40U/ul) and 1 µl of  Reverse transcriptase (Revert Aid H 
minus) (200 units/μl) (Thermoscientific, USA). 10 µl from the master 
mix was aliquated to each reaction mixture tube and then mixed 
properly. Reverse transcription was carried out by incubating the 
reaction mixture at 42°C for 60 min and MMLV-RT was inactivated 
by incubating the tube at 70°C for 10 min.The cDNA was stored at -
20°C till further use in PCR.  
The PCR master mix consisted of 2.5 µl of 10X magnesium free 
PCR buffer (10 mM Tris-HCl, 50 mM KCl, 0.1% Triton X), 1.5 µl of 
25 mM MgCl2, 1.0 µl of 10 mM dNTP, 1.0 µl each of (20 pmol) 
forward and reverse primers, 0.5 µl of 1.0 U/µl Taq DNA 
polymerase (promega, USA), 11.5 µl of NFW to which 1 µl of cDNA 
was added. The PCR was carried out by GeneAmp® PCR system 
9700 thermal cycler machine (Applied biosystems
®
, USA). The 
cycling conditions were initial denaturation at 95°C for 5 min, 35 
cycles of 94°C/30 s denaturation, 58°C/30 s primer annealing and 
72°C/30 s extension followed by final extension of 72°C for 10 min. 
The RT-PCR product was resolved on 1.5% agarose gel in 1X TAE 
buffer. 100 bp DNA ladder (Fermentas, USA) was used as marker 
to determine the size of RT-PCR products. Gel was stained with 
ethidium bromide (Life Technologies, USA) and visualized by UV 





imaging system, BIORAD, USA). 
 
 
Virus isolation and identification from blood sample 
 
Virus isolation was carried out according to the procedure des-
cribed by Oura et al. (2009). Briefly, blood samples were washed 
three times with PBS and sonicated as described in the OIE manual 
(OIE, 2008). BHK-21 cells were inoculated with 500 µl of washed 
blood and incubated overnight at 26°C. The following day, the 
inoculum was removed and replaced with fresh DMEM (GIBCO 
TM
, 
UK) (1% pen/strep, 1% Amphotericin B, 10% FCS). Cells were 
incubated 26°C for 7 days and then harvested by centrifugation at 
2400 ×g for 5 to 10 min, supernatant was tested by nested RT-PCR 
for the presence of BTV RNA. 
 
 
Data management and analysis  
 
The data was collected and stored in Microsoft excel spreadsheet 
format and analyzed using SPSS version 18 software program 
(SPSS Inc. Chicago, IL, USA). The prevalence was calculated as 
the number of sample positive, divided by the total number of sam-
ple examined. The association between the risk factors and the 
outcome variables was assessed using chi-square (x
2
) test. Uni-and 
multivariate logistic regressions were used to investigate possible 
associations between the seroprevalence and the explanatory 




RESULTS AND DISCUSSION 
 
Of the 91 small ruminants examined, 26 (28.6%) were 
found to harbor BTV antibody by c-ELISA. Similarly, spe-
cies level prevalence of BTV antibody was 8 (13.8%) and 
18 (54.5%) in sheep and goats respectively. Multiva-lent 
analysis of risk factors showed that risk factors like sex, 
age and body condition had no significant (P>0.05) impact 
on the c-ELISA result. However, significant (P<0.05) dif-
ference was observed in the prevalence of BTV antibody 
between sheep and goat (Table 2). 
Of the 91 sheep and goat serum tested for neutralizing 
antibody for the four locally prevalent serotypes of blue 
tongue virus (BTV 1, 2,10, and 23) serotypes, only one 
sheep (animal code number 3) had detectable neutrali-
zing antibody against BTV 1 serotype measured by SNT




Table 2. Multivariate analysis of risk factor with seroprevalence of the BT virus antibody in sheep 
and goats. 
 




Female 12 (34.3) 35 2.1 0. 91(0.36)
a
 
Male 14 (25.0) 56 1.5  
Total 26 (28.6) 91   
     
Body condition 
Good  14 (23) 61 7.5 2.864(0.091)
a
 
Poor 12 (40) 30 6.03  
Total  26 (28.6) 91   
     
Age      
Adult 26 (31.3) 83 1.002 3.508(0.061)
a
 
Young 0 (0) 8 6.52  
Total 26 (28.6) 91   
     
Species of animal 
Sheep  8 (13.8) 58 0.521 17.111(0.0000)
b
 
Goat  18 (54.5) 33 0.233  
Total  26 (28.6) 91   
 
a  
No significant association (P>0.05), 
b




   
 
Figure 1. (a) Cell growth and no CPE in the serum neutralization test showing confluent 
growth of BHK-21 cells after 4 days of incubation at 1:16 serum dilution taken from animal 
code number 3. (b) CPE observed at 1:2 dilutions in other sheep and goat sampleS 




with titers 1.2 log10 (Figure 1). 
The blood sample was collected from 26 c-ELISA posi-
tive animals for the detection of dsRNA of BT virus and 
found negative in nested RT-PCR (Figure 2).  
The study also attempted to isolate BT virus from the 
blood sample; however, there was no growth of virus in 
the BHK-21 cells after 7 days of incubation and three 
blind passages. 
BT has been reported in several states of India, inclu-
ding northern (Haryana, Himachal Pradesh, Jammu and 
Kashmir, Punjab, Rajasthan and Uttar Pradesh), central 
(Madhya Pradesh), western (Gujarat and Maharashtra) 
and southern areas (Andhra Pradesh, Karnataka, Kerala 
and Tamil Nadu). However, there are no reports on BT in 
the north-eastern states of India (Prasad, 2000; Mertens 
et al., 2008) 
In the present study, an overall seroprevalence of 
28.6% (26) BTV antibody in sheep and goats was found. 
It was also found that 13.8% (8) sheep and 54.5 % (18) 
goats were seropositive in the study. Significant (P<0.05) 
difference was observed in the prevalence of BTV anti-
body between sheep and goat in which goats showed 
more seropositivity than sheep (Table 2). This finding is 
in agreement with different authors in India and abroad. 
Studies conducted in Andhra Pradesh during 1991 revea-
led a higher prevalence of antibodies to BTV in sheep




                                 
Lane M: Marker 
Lane 1: BTV 1 
Lane 2: BTV 2 
Lane 3: BTV 10 
Lane 4: BTV 23 
 
 
Figure 2. (a) Agarose gel showing 274 bp amplicon specific for NS1 gene of BTV 1, 2, 10 and 23 serotypes in RT-PCR. (b) 




and goats (45.71 and 43.56%, respectively) than in cattle 
(33.4%) and buffalo (20%) (Sreenivasulu et al., 2004). 
This higher prevalence in small ruminants may reflect 
their involvement in the basic ecology of the virus 
(Sreenivasulu et al., 2004). Khalid et al. (2012) reported a 
total seroprevalence of 43.82% (1436) in sheep and goat 
in Iraq by c-ELISA. According to Khalid et al. (2012), 
43.97% (1391) sheep were seropositive by c-ELISA which 
is very high as compared to the present study (13.8%). 
This could be due to the geographic nature of Iraq and 
the presence of rivers, wet lands such as the marshes, 
lakes, oasis and pools, and the humid hot climate espe-
cially in the southern parts of Iraq which provided a very 
suitable condition for the propagation of the Culicoides 
imicola, the main biting midges of the virus in Iraq (Khalid 
et al., 2012). 
In this study, 54.5% (18) goats were seropositive to BT 
virus antibodies which were in agreement with the result 
of Sreenivasulu et al. (2004) who reported 43.6% seropo-
sitivity in goats in Andhra Pradesh, India and Khalid et al. 
(2012) who reported 39.47% positivity in goats in Iraq. On 
the contrary, low levels of antibody (2.63 and 5.3%), were 
also detected by Ravishankar et al. (2005) and Doddamani 
and HariBabu (2006) in Kerala and Karnataka, respec-
tively. Vengadabady et al. (2006) reported the occurrence 
of BT in goats in the Coimbatore District of Tamil Nadu, 
with 13% morbidity and 2.3% mortality; however, these data 
are based mainly on historical information and clinical 
diagnosis.  
This study identified higher seroprevalence among goats 
indicating that goats would be the most important animals 
in the epidemiology of BTV with less clinical manifesta-
tion due to development of acquired immunity as a result 
of continuous exposure. Sheep which are highly suscepti-
ble animals to BT show clinical signs and die due to the 
infection. However, in the goats, clinical manifestation is 
less and they can be tested positive. 
On the basis of multivalent logistic regression analysis,  
it was also detected that risk factors like sex, age and 
body condition had no significant (P>0.05) impact on the 
seroprevalence (Table 2). This is in contrast with the 
results of Christie (2010) who found that flock level sero-
prevalance was higher among the adult population (25.93%) 
than young animals (3.7%). This disagreement is due to 
the fact that the numbers of young animals included in 
this study are small and all are seronegative which in turn 
has impact on the data analysis. 
Of the 91 sheep and goat serum tested for neutralizing 
antibody for the four locally prevalent serotypes of  blue-
tongue virus (BTV 1, 2, 10 and 23) serotypes, only one 
sheep (animal code number 3) had detectable neutral-
lizing antibody against BTV 1 serotype measured by m-
SNT with titers 1.2 (log10). This is because antibodies 
detected by the c-ELISA are directed against the group-
specific inner capsid protein (VP-7) and may not be neu-
tralizing antibodies which are directed against serotype-
specific VP-2 (Huismans and Erasmus, 1981; Oura et al., 
2009). Oura et al. (2009) reported that there is a good 
correlation between the presence of neutralizing antibo-
dies at the time of challenge and both clinical and virolo-
gical protection suggests that, if an animal has neutrali-
zing antibodies to a particular serotype present at the 
time of challenge, it is likely to be protected against that 
serotype.  
The blood sample was collected from c-ELISA positive 
animals for the detection of BT genomes and found nega-
tive in RT-PCR. This result is in accordance with Christie 
(2010) who detected viral RNA and clinical signs higher 
in the lamb population than adults. All our lambs were 
seronegative so that lamb blood samples were not tested 
by nested RT-PCR. The c-ELISA positive animals were 
adult and it could be due to the development of group 
specific antibody after long time and frequent exposure of 
small amount of antigen. However, the study did not 
identify any active clinical disease and infection so, there 
was no active virus in the body of study animals. 




The study was also attempted to isolate BT virus from 
the blood sample; however, there was no growth of virus 
in the BHK-21 cells after 7 days of incubation. The rea-
son for this result is also the same with the absence of 





BT is a reportable disease of considerable socioecono-
mic concern and of major importance for the international 
trade of animals and animal products. BT has been re-
ported in several states of India including in this study 
area. BT affects a substantial number of sheep within India 
and the prevalence is distributed heterogeneously through-
out most states of the country. This study reveals high 
seroprevalence of BT in goats by c-ELISA and goats are 
very important in the epidemiology of the disease because 
they do not show any clinical sign; however, they could 
be source for transmission of the virus through appro-
priate Culicoides biting midges. m-SNT result in this study 
also shows that there are antibodies against BT which 
are not neutralizing against locally prevalent viral strains. 
Higher seroprevalence among adults suggests continued 
exposure with the development of an acquired immune 
response, whereas no detection of nucleic acid, virus 
isolation and no concurrent observation of clinical signs is 
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